Related Experiment Video
Updated: Sep 13, 2025
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Genetic profiling and pathway analysis in bladder carcinoma: Implications for therapeutic targeting
Sampara Vasishta1, Usha Sachidananda Adiga1, Alfred J Augustine2
1Department of Biochemistry, Apollo Institute of Medical Sciences and Research Chittoor, Murukambattu, Andhra Pradesh, India.
Objective:
Bladder carcinoma represents a significant challenge in oncology due to its heterogeneous molecular nature. This study aimed to identify key genetic factors and molecular pathways involved in bladder carcinoma pathogenesis to facilitate the development of targeted therapies.
Material And Methods:
The top 30 genes associated with bladder carcinoma were retrieved from the disease gene network database. Comprehensive bioinformatic analysis was performed using various enrichment tools, including gene ontology biological process, cellular component, molecular function analyses, and pathway mapping through WikiPathways and metabolite associations through human metabolome database. Drug interactions were evaluated using DrugMatrix data.
Results:
Gene ontology analysis revealed significant enrichment of cancer-related biological processes, cellular components, and molecular functions. Pathway analysis identified strong associations with head and neck squamous cell carcinoma, cancer pathways, pleural mesothelioma, endometrial cancer, and bladder cancer pathways. Key genes including CDKN2A, PTEN, EGFR, PIK3CA, HRAS, FGFR3, and TP53 were implicated across multiple pathways. Metabolite analysis showed significant associations with phosphatidylinositol derivatives, highlighting the importance of the PI3K pathway. Drug interaction analysis revealed potential modulatory effects of several compounds including sertraline, valproic acid, and hydroxyurea on gene expression patterns in bladder carcinoma.
Conclusion:
This study provides comprehensive insights into the molecular underpinnings of bladder carcinoma, highlighting interconnected pathways and potential therapeutic targets. The significant overlap with other cancer types suggests common oncogenic mechanisms that could be exploited for therapeutic intervention. Further validation of these findings in clinical samples may facilitate the development of personalized treatment approaches for bladder carcinoma patients.
Insights
This study identifies key genes and pathways in bladder carcinoma, revealing common mechanisms with other cancers. Findings suggest potential targeted therapies and personalized treatment approaches for bladder cancer patients.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Bladder carcinoma is a complex cancer with diverse molecular characteristics.
- Understanding its genetic factors and pathways is crucial for developing targeted therapies.
Purpose of the Study:
- To identify key genetic factors and molecular pathways in bladder carcinoma pathogenesis.
- To facilitate the development of targeted therapies for bladder cancer.
Main Methods:
- Retrieved top 30 bladder carcinoma-associated genes from a disease gene network database.
- Performed comprehensive bioinformatic analysis including gene ontology and pathway mapping.
- Evaluated drug interactions using DrugMatrix data.
Main Results:
- Gene ontology analysis revealed enrichment in cancer-related biological processes and functions.
- Pathway analysis indicated strong associations with various cancer types, including bladder cancer.
- Identified key genes (e.g., CDKN2A, PTEN, TP53) and highlighted the PI3K pathway; noted potential drug modulatory effects.
Conclusions:
- The study offers insights into bladder carcinoma's molecular basis and identifies potential therapeutic targets.
- Overlapping oncogenic mechanisms with other cancers suggest broader therapeutic strategies.
- Further clinical validation could lead to personalized bladder cancer treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...